About UCLA Neuro-Oncology Program
Clinical Trials at UCLA Neuro-Oncology Program
During the past decade, UCLA Neuro-Oncology Program conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "UCLA Neuro-Oncology Program"
#1 collaborator was "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at UCLA Neuro-Oncology Program
According to Clinical.Site data, the most researched conditions in "UCLA Neuro-Oncology Program" are
"Glioblastoma Multiforme" (3 trials), "Multiple Myeloma" (2 trials), "Brain Cancer" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials) and "Glioblastoma" (1 trials). Many other conditions were trialed in "UCLA Neuro-Oncology Program" in a lesser frequency.
Clinical Trials Intervention Types at UCLA Neuro-Oncology Program
Most popular intervention types in "UCLA Neuro-Oncology Program" are "Drug" (5 trials), "Biological" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Nivolumab" (2 trials), "Bevacizumab" (1 trials), "CC-122" (1 trials), "CC-223" (1 trials) and "Carmustine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at UCLA Neuro-Oncology Program
The vast majority of trials in "UCLA Neuro-Oncology Program" are
6 trials for "All" genders.
Clinical Trials Status at UCLA Neuro-Oncology Program
Currently, there are NaN active trials in "UCLA Neuro-Oncology Program".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in UCLA Neuro-Oncology Program,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in UCLA Neuro-Oncology Program, 3 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".